跳至主要内容
临床试验/TCTR20210829002
TCTR20210829002已完成1 期

High-dose proton pump inhibitor versus standard-dose proton pump inhibitor in PPI-based triple therapy for Helicobacter pylori eradication in Lampang hospital: A randomized controlled trial

ational Research Council of Thailand (NRCT)0 个研究点目标入组 150 人开始时间: 2021年8月29日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

High-dose PPI based triple therapy achieves higher eradication rate of H. pylori infection than standard-dose PPI based triple therapy for first-line treatment with no difference in side effects.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • 1. Adult patients age greater than or equal to 18 years old, 2. H. pylori infection, 3. Did not receive prior eradication therapy

排除标准

  • 1. history of gastric cancer or gastrectomy, 2. severe concurrent disease or malignancy, 3. pregnant or lactating, 4. alcohol abuse or drug addiction, 5. previous allergic reaction to study drugs, 6. history of taking PPI, bismuth or antibiotics within 4 weeks, 7. subjects declined to participate

研究者

发起方
ational Research Council of Thailand (NRCT)

相似试验